Paracetamol, adrenaline and insulin among new drugs banned from parallel export

Paracetamol, adrenaline and insulin among new drugs banned from parallel export

More than 80 medicines have been banned from parallel export, to ensure a consistent supply for UK patients who need them during the coronavirus pandemic.

Related Article: ‘Little capacity’ to deliver NHS reforms without primary care investment

The ‘crucial’ medications – including adrenaline, insulin, paracetamol and morphine – are commonly used in secondary care and are needed to treat patients who are seriously ill with Covid-19.

It is hoped that banning the drugs from parallel export – the practice of companies selling drugs intended for the UK market to other countries for profit – will help to minimise disruption to the supply chain, and protect against supply shortages.

Announcing the restrictions, the Department of Health and Social Care said any firms found to be in breach of the ban could face tough sanctions from Medicines and Healthcare products Regulatory Agency.

Related Article: Pharmacy First could help reduce AMR, suggests report

Health minister Lord Bethell said: ‘Our brilliant NHS staff are going above and beyond to provide world-class care to patients with coronavirus and we are supporting them in every way we can.

‘We are today banning the parallel export of more than 80 crucial medicines to protect patients in the UK and help ensure they can always get the treatments they need.’

Related Article: OBE award the ‘pinnacle of my career’ says community pharmacist

The full list of all medication that cannot be parallel exported, including the new additions, can be viewed here.

Want news like this straight to your inbox?
Sign up for our bulletins
Have your say

Leave a Reply

Your email address will not be published. Required fields are marked *

Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.